Johnson & Johnson Hit With $8 Billion Jury Verdict in Risperdal Suit

h s October 08, 2019

A Philadelphia jury found that a subsidiary downplayed the risks that the anti-psychotic drug could lead to breast growth in boys.

from Health https://ift.tt/2OvB8B3